Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma's Patent Cliff Puts China Front and Center
For pharmaceutical firms, watching the lucrative patents on their top-selling drugs expire has long been part of the business cycle. There's enormous pressure to find ways of covering the shortfall. For the first time, China has something to offer.
China hosts major pharma and med-tech expo, gathering more than 1,000 industry specialists
China's Boao Lecheng International Medical Tourism Pilot Zone in Hainan has become a hub for global medical innovation, thanks to hosting the 1st Global Innovative Pharmaceutical and Medical Device Expo, along with the 4th International Conference…
Charudutta Panigrahi | Will Odisha Pharma Summit 2025 Be a Defining Moment for Eastern India?
Odisha is preparing to host the Odisha Pharma Summit 2025, a landmark event that could redefine the state's industrial trajectory. Positioned as a gateway for pharmaceuticals and MedTech, the conclave is more than just a showcase — it is a…
Telangana govt, Pharma companies inks for invest ₹9,500 cr
The Telangana government has inked MoUs with a number of pharma companies for a total investment of ₹9,500 crore in new projects. The MoUs were announced at the Telangana Rising Gobal Summit in Bharat Future City here on Tuesday.
Royalty Pharma (NASDAQ:RPRX) EVP Sells $913,526.10 in Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 23,334 shares of Royalty Pharma stock in a transaction on Friday, December 5th. The stock was sold at an average price of $39.15, for a total value of $913,526.10. Following…
Novo Nordisk now wants Sun Pharma to stop dealing in weight loss drug compound, goes to Delhi HC again
Danish pharma giant Novo Nordisk has moved the Delhi High Court seeking to restrain Indian company, Sun Pharmaceutical, from directly or indirectly dealing in semaglutide, an active pharmaceutical ingredient in the blockbuster drug Ozempic, or any…
Monolithic Power, Ascendis Pharma And More: CNBC's 'Final Trades' - Ascendis Pharma (NASDAQ:ASND), Goldman Sachs Nasdaq-100 Premium Income ETF (NASDAQ:GPIQ)
On CNBC's “ Halftime Report Final Trades,” on Monday, Amy Raskin, chief investment officer at Chevy Chase Trust, named Ascendis Pharma A/S (NASDAQ:) as her final trade. According to recent news, the U.S. Food & Drug Administration…
Ascendis Pharma A/S (NASDAQ:ASND) Shares Down 4.2% - Here's Why
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report)'s stock price dropped 4.2% on Tuesday. The stock traded as low as $198.16 and last traded at $198.4740. Approximately 116,561 shares changed hands during mid-day trading, a decline of 76% from the…
89,312 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by WINTON GROUP Ltd
WINTON GROUP Ltd bought a new stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 89,312 shares of the company's stock, valued at…
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells 40,000 Shares of Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 40,000 shares of the firm's stock in a transaction that occurred on Thursday, December 4th. The shares were sold at an average price of $74.40, for a total value of…
Telangana's EODB measures, infrastructure, talent come for praise
Telangana's single window system of according time bound approvals for industrial projects, talent pool, infrastructure as well as policy measures to spur innovation came in for rich praise from speakers at a panel discussion forming part of the…
13 Lakh Jobs through Bharat Future City: Sridhar Babu
Speaking at a global summit on Tuesday, he explained the government's plans under the theme “Bharat Future City, as a magnet for $3 Trillion Telangana.” He said this next-generation city will be built as a zero-carbon city equipped…
Why Novo Nordisk has moved Delhi HC against Sun Pharma
Semaglutide, the active ingredient in Novo's GLP-1 drugs (Ozempic, Wegovy, and Rybelsus), was initially developed for type-2 diabetes but later approved for obesity treatment. Clinical studies showed 15-23% weight loss with its use. In India…
Modest economic growth forecasted for Switzerland in 2026
Persistent uncertainty and a weak global investment cycle are likely to dampen the export and capital goods industry, the Basel-based institute indicated on Tuesday. In concrete terms, as already forecasted in August, the market research institute…
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Core & Main (NYSE:CNM), Eshallgo (NASDAQ:EHGO)
NeoVolta (NASDAQ:) shares rose 8.9% to $3.79 during Tuesday's pre-market session. The market value of their outstanding shares is at $120.8 million. Erayak Power Solution Gr (NASDAQ:) shares increased by 8.67% to $5.01. The market value of their…
Receive a Daily briefing on Pharma Industry News
Get Started